MedPath

A prospective interventional study evaluating the safety and efficacy of trans-nasal hybrid endoscopic submucosal dissection for the treatment of early gastric cancer

Not Applicable
Recruiting
Conditions
early gastric cancer/adenoma
Registration Number
JPRN-UMIN000032615
Lead Sponsor
TT Medical Center Tokyo
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
20
Inclusion Criteria

Not provided

Exclusion Criteria

1. Hb < 9 g/dl 2. Pregnant women 3. Patients with severe heart/kidney/liver diseases 4. Patients in disagreement with informed consent 5. Others

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath